Ground News

Amgen image

News from Amgen

Stay current with all the latest and breaking news about Amgen, compare headlines and perspectives between news sources on stories happening today. In total, 146 stories have been published about Amgen which Ground News has aggregated in the past 3 months.

Covered Most By

biopharmadive.com

Suggest a source

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Amgen News

Mouse protein disrupts cancer-causing epigenetic changes in human colorectal cancer

Mouse protein disrupts cancer-causing epigenetic changes in human colorectal cancer

75% Center coverage: 4 sources

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.See the Story

FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation - Amgen (NASDAQ:AMGN)

FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation - Amgen (NASDAQ:AMGN)

100% Center coverage: 3 sources

The Food and Drug Administration approved Amgen Inc‘s (NASDAQ:AMGN) Lumakras (sotorasib) in combination with Vectibix (panitumumab) for KRAS G12C-mutated metastatic colorectal cancer (mCRC), who have received prior fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy. Approval is based on the pivotal Phase 3 CodeBreaK 300 study, which demonstrated that Lumakras plus Vectibix is the first and only targeted treatment combination for …See the Story

Unpacking the Latest Options Trading Trends in Amgen - Amgen (NASDAQ:AMGN)

Unpacking the Latest Options Trading Trends in Amgen - Amgen (NASDAQ:AMGN)

100% Center coverage: 1 sources

Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven analysts that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation, twelve have given a buy recommendation and one […]See the Story

Latest News Stories

Breaking News Topics Related to Amgen